INCREASES FOR ALL DRUGS AND SPECIALITY DRUGS

3.78%: Overall predicted inflation rate for all pharmaceuticals
4.33%: Overall predicted inflation rate for specialty drugs

• 4.25%: Injectables (76.74% of total market)
• 4.49%: Non-injectables (23.26% of total market)
• 4.18%: Biologic (73.05% of total market)
• 4.73%: Non-biologic (26.95% of total market)

PROJECTED INFLATION RATES FOR KEY THERAPEUTIC CLASSES

4.80%: Immunomodulators and biologics (19.74% of drug spend)
4.80%: Pediatrics (19.74% of drug spend)
3.85%: Oncology (23.05% of drug spend)
3.74%: Plasma critical care (4.11% of drug spend)
3.69%: Cardiology (2.70% of drug spend)
3.55%: Infectious diseases (12.55% of drug spend)
2.76%: Diabetes (3.70% of drug spend)

INCREASES IN PHARMACIST BILLING FROM 2018 TO 2021

772%: Clinics
29%: Urgent care
28%: Ambulatory surgery centers 
25%: Hospital outpatient departments

SPECIALITY PHARMACY TRENDS

315%: Specialty pharmacies growth between 2015 and 2021
85%: Estimated percent of integrated delivery networks and health systems with their own specialty pharmacy program in 2022, up from 70% in 2019
55%: Specialty medications percentage of total pharmaceutical spend in 2021, up from 28% in 2011

LARGEST DRUG PERCENTAGES ON PROVISTA’S SPECIALITY PHARMACY LIST

32.5%: Oncology therapies (195 drugs)
13.8%: Infectious disease (83 drugs)
11.8%: Neurology (71 drugs)

HOW SPECIALTY MEDICATIONS ARE DISTRIBUTED

65%: Limited distribution channel
56%: Orphan drug status
35%: Biologics

Source: Pharmacy Market Outlook for Winter 2023